Peer-reviewedLicence not statedTherapies
Isotonitazene, a synthetic opioid from an emerging family: The nitazenes
Related
- The gasdermin family in depression-associated neuroinflammation: established evidence, emerging mechanisms, and therapeutic perspectives
- Opioid addiction vs. sugar addiction: Mesocorticolimbic stimulation controls motivation for remifentanil or alternative reward
- Suzetrigine-evoked analgesia is potentiated by Nav1.7 null-related opioid mechanisms.
- Differential Time-Course Decreases in Nonselective, μ-, δ-, and κ-Opioid Receptors After Focal Cerebral Ischemia in Mice
- Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced μ-Opioid Receptor Regulation
BibTeX
@article{eiden2026isotonitazene,
title = {{Isotonitazene, a synthetic opioid from an emerging family: The nitazenes}},
author = {Céline Eiden and Margot Lestienne and Sabrina Cherki and David Gautre and Thomas van den Broek and Olivier Mathieu and Hélène Peyrière},
journal = {Therapies},
year = {2026},
month = oct,
doi = {10.1016/j.therap.2024.05.004},
url = {https://hal.science/hal-05784852v1},
}
RIS
TY - JOUR
TI - Isotonitazene, a synthetic opioid from an emerging family: The nitazenes
AU - Céline Eiden
AU - Margot Lestienne
AU - Sabrina Cherki
AU - David Gautre
AU - Thomas van den Broek
AU - Olivier Mathieu
AU - Hélène Peyrière
PY - 2026
DA - 2026/10/07
JO - Therapies
DO - 10.1016/j.therap.2024.05.004
UR - https://hal.science/hal-05784852v1
SN - 0040-5957
SN - 1958-5578
ER -